Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations by Fischer, Yvan et al.
Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and
GLUT1 in Isolated Rat Cardiac Myocytes
EVIDENCE OF THE EXISTENCE OF DIFFERENT INTRACELLULAR GLUT4 VESICLE POPULATIONS*
(Received for publication, September 27, 1996, and in revised form, December 13, 1996)
Yvan Fischer‡§, Julia Thomas‡, Lidia Sevilla¶i, Purificación Muñoz¶**,
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Using isolated rat cardiomyocytes we have examined:
1) the effect of insulin on the cellular distribution of
glucose transporter 4 (GLUT4) and GLUT1, 2) the total
amount of these transporters, and 3) the co-localization
of GLUT4, GLUT1, and secretory carrier membrane pro-
teins (SCAMPs) in intracellular membranes. Insulin in-
duced 5.7- and 2.7-fold increases in GLUT4 andGLUT1 at
the cell surface, respectively, as determined by the non-
permeant photoaffinity label [3H]2-N-[4(1-azi-2,2,2-trif-
luoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)propyl-2-
amine. The total amount of GLUT1, as determined by
quantitative Western blot analysis of cell homogenates,
was found to represent a substantial fraction (;30%) of
the total glucose transporter content. Intracellular
GLUT4-containing vesicles were immunoisolated from
low density microsomes by using monoclonal anti-
GLUT4 (1F8) or anti-SCAMP antibodies (3F8) coupled to
either agarose or acrylamide. With these different im-
munoisolation conditions two GLUT4 membrane pools
were found in nonstimulated cells: one pool with a high
proportion of GLUT4 and a low content in GLUT1 and
SCAMP 39 (pool 1) and a second GLUT4 pool with a high
content of GLUT1 and SCAMP 39 (pool 2). The existence
of pool 1 was confirmed by immunotitration of intracel-
lular GLUT4 membranes with 1F8-acrylamide. Acute in-
sulin treatment caused the depletion of GLUT4 in both
pools and of GLUT1 and SCAMP 39 in pool 2. In conclu-
sion: 1) GLUT4 is the major glucose transporter to be
recruited to the surface of cardiomyocytes in response
to insulin; 2) these cells express a high level of GLUT1;
and 3) intracellular GLUT4-containing vesicles consist
of at least two populations, which is compatible with
recently proposed models of GLUT4 trafficking in
adipocytes.
In mammalian cells, the facilitative uptake of glucose is
mediated by a group of specialized glucose transporters (for
reviews, see Refs. 1–4). Peripheral insulin-sensitive tissues,
such as fat, skeletal muscles, and heart, express a unique
transporter isoform (GLUT4),1 which is largely confined to an
intracellular storage site in the basal, nonstimulated state and
becomes recruited to the cell surface under the influence of
insulin (5, 6) but also other stimuli, such as contraction (7–9)
and hypoxia or anoxia (10, 11). This recruitment process is
likely to account for a large part of the increase in the rate of
glucose uptake observed on stimulation with these agents
(12–16).
It has been recently reported that mice expressing a defec-
tive GLUT4 gene show cardiac hypertrophy (17), which sup-
ports the view that GLUT4 is important for normal function
and properties of cardiac myocytes. This fact emphasizes the
necessity of a thorough understanding of the mechanisms in-
volved in the control and function of this protein in heart
tissue. An important issue is the delineation of the GLUT4
trafficking pathway(s) in cardiomyocytes. In this respect, im-
munoelectron microscopy studies performed in the rat heart
have observed that GLUT4 is localized in cardiac myocytes,
under nonstimulated conditions, in small tubulovesicular ele-
ments adjacent to the sarcolemma and the transverse tubular
system and in the trans-Golgi region (18), and that insulin
stimulates the recruitment of intracellular GLUT4 carriers to
the sarcolemma and to the T-tubular system. However, there is
no information on biochemical grounds regarding the charac-
teristics of the intracellular GLUT4 pool(s) in cardiomyocytes
and the proteins essential for recruitment to the cell surface in
response to insulin.
On the other hand, many cells types, such as endothelial
cells and erythrocytes and also fat and muscle cells, contain
another transporter isoform, GLUT1, which is thought to be at
least in part responsible for the basal uptake of glucose (19, 20).
In heart and skeletal muscle, the content of GLUT1 mRNA and
protein was shown to largely decrease during postnatal devel-
opment (21, 22), whereas the reverse is true for GLUT4 (21–
23). However, the adult heart still appears to contain consid-
erable amounts of GLUT1, in contrast to skeletal muscles (24,
25). Moreover, recent studies have shown that in heart muscle
cells GLUT1 is recruited to the plasma membrane by several
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types of glucose transport stimuli, including insulin (26, 27),
metformin (26), serotonin (27), and catecholamines (28). Thus,
it is conceivable that GLUT1 plays an important role in the
regulation of glucose uptake in the heart under certain physi-
ological conditions.
In view of the importance of glucose carriers in cardiac func-
tion, we have used freshly isolated cardiac myocytes from adult
rats: 1) to quantify the effect of insulin on the recruitment of
GLUT4 and GLUT1 carriers to the cell surface; 2) to compare
the amounts of these proteins expressed in intact cardiac myo-
cytes; and 3) to explore the nature of the intracellular GLUT4
compartment.
MATERIALS AND METHODS
Chemicals—125I-Protein A and 125I-sheep anti-mouse antibody were
purchased from ICN (Meckenheim, Germany). 125I-Goat anti-mouse
antibody, ECL, and 2-deoxy-D-[3H]glucose were from Amersham Corp.
The photoaffinity label (3H-ATB-BMPA) used to quantify the glucose
transporters was prepared as described elsewhere (29). All chemicals
for media used for cell isolation, glucose transport assays, and labeling
experiments were from Merck; antipain, a-hemolysin, protein A-Sepha-
rose, g-globulin, goat-anti mouse IgG, and goat anti-mouse IgM coupled
to agarose were obtained from Sigma; aprotinin, pepstatin, and leupep-
tin were from ICN; ThesitTM and bovine serum albumin (fraction V,
fatty acid free) were purchased from Boehringer Mannheim); purified
bovine insulin was a kind gift from Prof. Axel Wollmer (Aachen, Ger-
many). All chemicals were the highest purity grade available. Concen-
trated stock solutions of insulin (in medium A, see below) were stored at
220 °C in appropriate aliquots and diluted just prior to addition to the
isolated cardiomyocytes. Immobilon polyvinylidene difluoride was ob-
tained from Millipore. All electrophoresis reagents and molecular
weight markers were obtained from Bio-Rad.
Antibodies—Antisera directed against the C-terminal peptides of
either GLUT1 or GLUT4 (and used to purify the photoaffinity-labeled
transporters) were raised in rabbits in the laboratories of G. H. (GT1
and GT4), and A. Z. (OSCRX against GLUT4) or were a kind gift from
Dr. Samuel W. Cushman and Dina R. Yver (Bethesda, MD; 9301 pA and
8105p aG4). A polyclonal antibody generated against the C terminus of
GLUT1 obtained from Biogenesis Inc. was used for immunoblotting
assays. Monoclonal antibodies 1F8 (against GLUT4) and 3F8 (against
SCAMPs) were kindly provided by Dr. Paul F. Pilch (Boston Universi-
ty). A rabbit polyclonal antibody against rat b1-integrin was kindly
given by Dr. Carles Enrich (University of Barcelona) (30). Monoclonal
antibody NCL-DYS 1 against the midrod of dystrophin was obtained
from NovoCastra. The polyclonal antibody against the rat a1-subunit of
the Na1-K1-ATPase was from Upstate Biotechnology Inc. (Lake Placid,
NY). Polyclonal antibody 18B11, against TGN 38, was kindly given by
Dr. Ignacio Sandoval (Centro de Biologia Molecular, Madrid, Spain).
Isolation of Cardiomyocytes and Glucose Transport Assays—Car-
diomyocytes from adult female Sprague-Dawley rats (180–220 g, fed ad
libitum) were obtained as described previously (31). Treatment of car-
diomyocytes for all experiments was performed in medium A containing
6 mM KCl, 1 mM Na2HPO4, 0.2 mM NaH2PO4, 1.4 mM MgSO4, 128 mM
NaCl, 10 mM HEPES, 1 mM CaCl2, and 2% bovine serum albumin (fatty
acid free, pH 7.4) at 37 °C, equilibrated with oxygen. The rate of 2-de-
oxy-D-glucose uptake was determined as described elsewhere (31).
Photoaffinity Labeling of Glucose Transporters with [3H]ATB-
BMPA—The labeling of glucose transporters was performed according
to a method developed previously (12, 29), which was adapted and
extensively validated in cardiomyocytes (27, 28). In brief, the labeling of
cell surface transporters was carried out as follows. Cardiomyocytes
(;5 mg protein/sample in a total volume of 6 ml) were incubated for 30
min at 37 °C in the absence (control) or in the presence of insulin (10
nM). Parallel samples were used for the determination of glucose trans-
port. The cells allotted to the photoaffinity labeling were then washed
and resuspended in 500 ml of medium A (with or without insulin); 60 ml
of the nonpermeant, photoreactive bismannose compound 3H-ATB-
BMPA (300 mCi, 60 mM final concentration) were added immediately
before the samples were irradiated for 3 min with UV light under
continuous gentle shaking. Following irradiation the cells were washed
with medium A and then solubilized at 4 °C with 2% ThesitTM (in a
phosphate buffer containing the proteinase inhibitors antipain, aproti-
nin, pepstatin, and leupeptin, 1 mg/ml each).
Preliminary experiments were performed to ensure that amounts of
antibodies used to immunoprecipitate GLUT1 and GLUT4 from homog-
enized or permeabilized cardiomyocytes were saturating with respect to
glucose transporter recovery. First, larger amounts of anti-GLUT1 an-
tisera (up to 300 ml of GT1 or 50 ml of 9301pA) or GLUT4 antisera (up
to 300 ml of GT4 or 50 ml of p8105 aG4) or longer incubation times (up
to 18 h) did not result in increased GLUT1 or GLUT4 signals. Second,
no detectable amount of glucose transporters could be recovered from a
second immunoprecipitation with the same antiserum. Third, the total
signals obtained were independent of the antiserum used (GT4 or GT1,
raised in the laboratory of G. H., versus p8105 aG4 or 9301pA). Finally,
as shown in a previous study, the order of addition of antibodies has no
influence on the results (13).
Determination of Total Cellular Amounts of GLUT4 and GLUT1 by
Quantitative Western Blot Analysis—Nonstimulated cardiomyocytes
(;30 mg protein/sample) were washed once with TES buffer (20 mM
Tris, 1 mM EDTA, 250 mM sucrose, and 0.1 mM phenylmethylsulfonyl
fluoride, pH 7.4) and then homogenized with a Potter (clearance, 0.2
mm) in a total volume of 4.7 ml. The samples were then spun down for
30 min at 50,000 g at 4 °C, and the pellet of this centrifugation was
resuspended in 350 ml of TES buffer. This crude membrane fraction was
used to perform immunoblot analysis, as described in a separate section
below. The absolute amounts of GLUT4 and GLUT1 were quantified by
comparing the signals obtained from several dilutions of crude mem-
branes with those of known standards. These standards were purified
intracellular membranes from isolated adipocytes (GLUT4) or from
human erythrocytes (GLUT1) in which the amount of D-glucose-dis-
placeable cytochalasin B binding sites had been determined as de-
scribed elsewhere (32).
Preparation of Purified Membrane Fractions from Cardiomyocytes—
Cardiomyocytes were incubated for 30 min at 37 °C in the presence or
absence of insulin (10 nM) and were washed once with TES buffer and
then immediately frozen in liquid nitrogen in a ratio of 107 cells/2.7 ml
of TES. Membrane fractionation was performed as described previously
(26).
Protocols of Vesicle Immunoisolation—Protein A-purified monoclonal
anti-GLUT4 antibody (1F8) or a corresponding amount of nonspecific
antibodies (g-globulins) was coupled to acrylamide beads (Reacti-gel GF
2000, Pierce) at a concentration of 1 mg of antibody/ml of resin accord-
ing to the manufacturer’s instructions. Before use, the beads were
saturated with 1% bovine serum albumin in PBS (134 mM NaCl, 2.6 mM
KCl, 6.4 mM Na2HPO4, and 1.46 KH2PO4, pH 7.4) for at least 30 min (at
room temperature) and washed with PBS. Intracellular membranes
(low density microsomes (LDMs)) were incubated with beads overnight
at 4 °C (50 mg of LDMs, 20-ml beads). The beads were spun down; the
supernatant was taken for later analysis; the beads were washed five
times with PBS; and the adsorbed material was eluted with electro-
phoresis sample buffer (0.1 M Tris-HCl, 20% glycerol, and 2% sodium
dodecyl sulfate, pH 6.8), incubated for 5 min at 95 °C, cooled, and
microcentrifuged. The supernatant fraction from the vesicle immuno-
adsorption assay and the immunoadsorbed extract were subjected to
immunoblot analysis.
In some assays, antibodies 1F8 (5–7 mg) and 3F8 (3 mg) were incu-
bated overnight at 4 °C with goat anti-mouse IgG or goat anti-mouse
IgM coupled to agarose (75 ml of bead volume). Beads were collected by
a 6-s spin in a Microfuge and washed in PBS. LDM preparations (15–25
mg of proteins) were incubated with 1F8- or 3F8-agarose overnight at
4 °C in the absence of detergents (0.1% bovine serum albumin and 1 mM
EDTA in PBS; final volume, 200 ml). The agarose beads and vesicles
bound to them were collected by a 6-s spin in a Microfuge. The vesicles
that were bound to the immobilized antibody were washed in PBS. The
adsorbed material was eluted with electrophoresis sample buffer.
The immunotitration experiments illustrated in Figs. 4 and 5 were
performed with antibodies bound to acrylamide beads prepared as
described above. LDM membranes (50 mg) were incubated overnight at
4 °C with different mixtures of two batches of beads (one batch with 1F8
and one with g-globulin as nonspecific antibodies), corresponding to
varying amounts of 1F8 (0–7 mg) in a constant total bead volume of 20
ml. The adsorbed and nonadsorbed membranes were then processed as
described above.
Immunoblot Analysis—SDS-polyacrylamide gel electrophoresis was
performed on a membrane protein following the method of Laemmli
(33). Proteins were transferred to Immobilon as previously reported (34)
in buffer consisting of 20% methanol, 200 mM glycine, and 25 mM Tris,
pH 8.3. Following transfer, the filters were blocked with 5% nonfat dry
milk and 0.02% sodium azide in PBS for 1 h at 37 °C and were incu-
bated with antibodies in 1% nonfat dry milk and 0.02% sodium azide in
PBS. Transfer was confirmed by Coomassie Blue staining of the gel
after the electroblot. Detection of the immune complex with the rabbit
polyclonal antibodies was accomplished using 125I-protein A for 4 h at
room temperature. Detection of the immune complex with monoclonal
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antibodies was performed using sheep anti-mouse 125I-labeled anti-
body. Antibody 3F8 was detected using horseradish peroxidase linked
to a goat anti-IgM mouse secondary antibody and visualized using an
ECL system. The autoradiograms were quantified using scanning den-
sitometry. Immunoblots were performed under conditions in which
autoradiographic detection was in the linear response range.
RESULTS
Effects of Insulin on Cell Surface Content of GLUT4 and
GLUT1 and Quantification of Total Glucose Transporter Con-
tent of Cardiomyocytes—To quantify the effect of insulin on cell
surface GLUT4 and GLUT1 we used the selective, nonper-
meant, photoreactive bismannose compound 3H-ATB-BMPA,
which has proven to give a more accurate picture of cell surface
changes than classical membrane fractionation methods com-
bined with Western blot analysis (12, 14, 16). ATB-BMPA
labeling was performed according to a protocol that has previ-
ously been successfully used in adipocytes (12, 13, 35) or skel-
etal muscles (14–16) and that we have recently adapted to
isolated cardiac muscle cells (27, 28).
Fig. 1 summarizes the quantitative data on the effects of
insulin on the content of glucose transporters at the surface of
cardiomyocytes. The hormone induced 5.7- and 2.7-fold in-
creases in the amounts of GLUT4 and GLUT1, respectively, in
this compartment (Fig. 1, left and middle panels). By compar-
ison, insulin caused a 12.0 6 0.74-fold stimulation of glucose
transport in the same experiments (Fig. 1, right panel). It is
worth mentioning that in the basal, i.e. nonstimulated, state
and in terms of absolute signals, the level of GLUT4 labeling at
the surface of cardiomyocytes already exceeded that of GLUT1
labeling by a factor of ;2.5 (not shown), so that with insulin
treatment, there was about four times more GLUT4 than
GLUT1 at the cell surface. Thus, the insulin-dependent in-
crease in glucose transport is largely explained by a recruit-
ment of glucose transporters (mainly GLUT4). The difference
in the extent of GLUT translocation and glucose transport
stimulation might be due either to a change in intrinsic activity
of recruited transporters or to a slightly higher accuracy of the
transport assay in comparison with the labeling method.
It should be noted that the quantitative evaluation of the
effects of insulin and the comparison of GLUT1 and GLUT4
relies on the assumption that the hormone does not modify the
reactivity of the cell surface transporters, and that both iso-
forms display the same labeling efficiency. In this context, it
was previously shown that the Kd of ATB-BMPA binding is
similar for both carrier isoforms and is not altered by insulin
(36). Importantly, the Ki value found for the inhibition of glu-
cose transport by ATB-BMPA in cardiomyocytes (;180 mM; not
shown) was similar to that determined in erythrocytes (29), rat
adipocytes (13), and 3T3-L1-adipocytes (36). The Ki was un-
changed with insulin treatment (13, 36). Moreover, incorpora-
tion efficiency of ATB-BMPA into GLUT1 and GLUT4 was
consistently found to be the same in different cell types, includ-
ing rat adipocytes (13, 37), 3T3-L1-adipocytes (36), and Xeno-
pus oocytes (37), and to be very high under the conditions used
(which were the same as in this study; Refs. 13, 29, and 36).
Finally, insulin had no effect on the total level of ATB-BMPA
incorporation as determined in cardiomyocytes permeabilized
with the pore-forming agent a-hemolysin or by sonication (data
not shown). This finding is in line with previous investigations,
which have shown that the total amount of labeled GLUT1 and
GLUT4 is the same in basal or insulin-stimulated 3T3-L1 adi-
pocytes (38) or muscle (14). Overall, these observations indicate
that the labeling of ATB-BMPA to cell surface glucose trans-
porters is independent of the cell type and is not affected by
insulin.
Although the results presented above point to GLUT4 as the
major transporter responsible for insulin-dependent glucose
uptake, reports indicating a relatively high expression of
GLUT1 in cardiac tissue (24, 25) prompted us to directly com-
pare the total amounts of GLUT4 and GLUT1 in isolated car-
diomyocytes by Western blot analysis. For this purpose, non-
stimulated cardiomyocytes were homogenized as described
under “Materials and Methods,” and their content in GLUT4
and GLUT1 was estimated by comparing the cell samples with
known standards obtained from intracellular adipocyte mem-
branes (GLUT4 standard) or erythrocyte membranes (GLUT1
standard). Using this method, we found contents of 1.2 pmol of
GLUT4 and 0.47 pmol of GLUT1/mg of protein (n 5 2). In other
words, GLUT1 makes up nearly 30% of the total glucose trans-
porter content in these cells. This substantial level of GLUT1
expression was essentially confirmed by experiments in which
we have attempted to determine the total amounts of GLUT1
and GLUT4 by using ATB-BMPA in cardiomyocytes permeabi-
lized with either a-toxin or by sonication. These experiments
even yielded a higher proportion of GLUT1 (up to 50%; data not
shown), although we cannot rule out that the labeling efficiency
of intracellular GLUT4 might be lower than that of GLUT1.
Characterization of GLUT4-containing Vesicles and Co-lo-
calization of GLUT4, GLUT1, and SCAMPs in Intracellular
FIG. 1. Quantitative analysis of the effects of insulin on cell surface labeling of GLUT4 and GLUT1 and on glucose transport in
intact cardiomyocytes. Cardiomyocytes were exposed to insulin (10 nM) for 30 min at 37 °C. The samples were then subjected to labeling,
solubilization, immunoprecipitation, and gel electrophoresis, and the amount of labeled transporters was determined as described under “Materials
and Methods.” The rate of 2-deoxy-D-glucose uptake was measured in parallel samples (right panel). Results shown are means of 16–18
independent experiments 6 S.E. (bars). The labeling data are expressed as values normalized to control. The statistical significance of the
differences from control was assessed by paired Student’s t test; ppp, p , 0.001 versus control.
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Membranes—In view of the fact that GLUT4 and GLUT1
showed differential recruitment to the cardiomyocyte surface
in response to insulin, and regarding the high level of GLUT1
expression in these cells, we decided to characterize the intra-
cellular insulin-sensitive GLUT4 pool and the degree of co-
localization of GLUT4 and GLUT1 in this compartment. In
addition, the distribution of SCAMPs has also been examined,
because these proteins have been reported to co-localize with
GLUT4 in isolated rat adipocytes (39, 40).
To this end, subcellular fractionation of isolated rat cardiom-
yocytes was performed as previously reported (26). This proce-
dure results in the isolation of several membrane fractions.
One of these fractions (PM, see “Materials and Methods”) was
enriched in the plasma membrane marker enzyme ouabain-
sensitive p-nitrophenylphosphatase (41) by a factor of 13.5
(2.40 versus 0.17 nmol/h/mg of protein), whereas the specific
activity of the sarcoplasmic reticulum marker, the EGTA-sen-
sitive Ca11-ATPase (42), was decreased by a factor of 3.6 (0.41
versus 1.88 nmol/h/mg of protein) when compared with crude
cell homogenates. PM was also highly enriched in cell surface
markers such as b1-integrin (Fig. 2), the a1-subunit of the
Na1-K1-ATPase, and dystrophin, as determined by immuno-
blot analysis (not shown). Another fraction (LDMs) contained
substantial amounts of GLUT4, GLUT1, and TGN 38 (a trans-
Golgi marker) and was nominally free from plasma membrane
markers or EGTA-sensitive Ca11-ATPase activity (data not
shown).
In keeping with prior observations (26) and with the data
shown in Fig. 1, the incubation of cardiomyocytes with insulin
caused a significant increase in GLUT4 and GLUT1 in plasma
membranes by 138 6 35% and 61 6 18%, respectively (Fig. 2).
The results indicate, in agreement with data illustrated in Fig.
1, that insulin causes a greater recruitment to the cell surface
of GLUT4 than GLUT1. Under the same conditions, no alter-
ations in the abundance of b1-integrin (Fig. 2), the a1-subunit
of the Na1-K1-ATPase, or dystrophin were detected (data not
shown). Concomitantly, there was a significant drop in the
abundance of GLUT4 and GLUT1 in LDMs after insulin treat-
ment (levels after insulin accounted for 40 6 8% and 48 6 6%
of control values, respectively; n 5 6–8 observations).
Western blot analysis of plasma and LDM membranes with
anti-SCAMP antibodies revealed two distinct bands showing
apparent molecular masses of 37 and 39 kDa (Fig. 2), as pre-
viously shown in adipocytes and skeletal muscle (39, 40). Acute
insulin treatment resulted in a redistribution of SCAMP 39
from LDMs to the plasma membranes (Fig. 2). Thus, insulin
caused a significant increase in the abundance of SCAMP 39 in
plasma membranes (94 6 5% increase) and a concomitant
significant decrease in LDMs (levels in the insulin-treated
group accounted for 55 6 8% of the unstimulated control group)
(Fig. 2). A similar tendency was found with regard to SCAMP
37, which did not reach significance in PM (37 6 34% increase
in PM and 26 6 7% decrease in LDMs after insulin treatment)
(Fig. 2).
We next characterized the degree of co-localization of
GLUT4, GLUT1, and SCAMPs in LDMs. To this end, we per-
formed two different types of vesicle immunoadsorption assays
with LDMs obtained from unstimulated cardiomyocytes: 1)
immunoadsorption of GLUT4-containing vesicles with 1F8 an-
tibody (monoclonal antibody against GLUT4) noncovalently
bound to agarose beads, and 2) immunoisolation of GLUT4
vesicles with 1F8 covalently linked to acrylamide beads. Im-
munoadsorption of GLUT4 vesicles with 1F8-agarose resulted
in the specific recovery of near 60% of total GLUT4 present in
LDMs (Fig. 3 and Table I); however, on adsorption with 1F8-
acrylamide, approximately 80% of all GLUT4 was specifically
recovered in the immunoprecipitates (Fig. 3 and Table I).
Based on this, we reasoned that this different efficiency of the
two protocols to immunoisolate GLUT4 vesicles may be used to
characterize the extent of co-localization of GLUT4 with other
proteins such as GLUT1 and SCAMPs in LDMs. As shown in
Fig. 3 and Table I, after immunoadsorption with 1F8-agarose,
only 15% of GLUT1 originally contained in LDMs was immu-
noadsorbed. Similarly, only 24% of SCAMP 39 was adsorbed to
FIG. 2. Effect of insulin on GLUT4, GLUT1, b1-integrin, and
SCAMP distribution in intracellular and plasma membranes
from cardiomyocytes. Isolated cardiomyocytes were incubated for 30
min with or without insulin (10 nM), as indicated, before PM and LDM
fractions were obtained as described under “Materials and Methods.”
GLUT4, GLUT1, b1-integrin, and SCAMPs were detected by immuno-
blot analysis by using specific antibodies. Equal amounts of membrane
proteins (5 mg for GLUT4, 15 mg for GLUT1, 30 mg for b-integrin, and
10 mg for SCAMPs) from PMs or LDMs were laid on gels. Representa-
tive autoradiograms, obtained after various times of exposure, of six to
eight separate experiments are shown.
FIG. 3. Immunoadsorption of GLUT4 and GLUT1 in intracel-
lular membranes from unstimulated cardiomyocytes. LDMmem-
branes obtained from nonstimulated cardiac myocytes were immuno-
adsorbed with 1F8-agarose beads (A) or with 1F8-acrylamide beads (B)
(1) or with beads covered with nonspecific antibodies (2). After the
incubation, the adsorbed fraction (pellet, P) and nonadsorbed fraction
(supernatant, S) were electrophoresed and immunoblotted to determine
the abundance of GLUT4 and GLUT1. Representative autoradiograms,
obtained after various times of exposure, of six to eight separate exper-
iments are shown.
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1F8-agarose (Table I). When using 1F8 coupled to acrylic
beads, four times as much GLUT1 and more than twice as
much SCAMP 39 were specifically immunoprecipitated when
compared with 1F8-agarose (i.e. 64% of all GLUT1 contained in
LDMs and 55% SCAMP 39; Fig. 3 and Table I). Thus, this
contrasts with the relatively small increase of 20% in GLUT4
recovery (i.e. 80% of total GLUT4 with 1F8-acrylamide versus
60% with 1F8-agarose; Fig. 3 and Table I).
Taken together, these results might be interpreted in terms
of the existence of two distinct intracellular GLUT4 membrane
populations in LDMs from unstimulated cardiomyocytes:
GLUT4 vesicles showing a low GLUT1 and SCAMP 39 content
and GLUT4 vesicles showing a high GLUT1 and SCAMP 39
content.
Immunoadsorption of LDMs was also carried out with anti-
bodies directed against SCAMPs (antibody 3F8 linked to aga-
rose beads). With this approach, nearly 63% of SCAMP 39 but
only 37% of GLUT4 and 25% of GLUT1 were recovered (Table
I). This finding suggests the existence of a subpopulation of
LDMs that is enriched in SCAMP 39 compared with GLUT4.
This type of analysis could not be extended to GLUT1 vesicles,
since the anti-GLUT1 antibodies used showed little efficiency
in immunoadsorbing GLUT1 vesicles (data not shown).
The conclusion that LDMs may contain at least two popula-
tions of GLUT4-containing vesicles, on the grounds of the im-
munoprecipitation experiments described above, is limited by
the fact that it is based on the comparison of data obtained from
two different protocols (adsorption with 1F8-agarose versus
adsorption with 1F8-acrylamide; Table I). To directly examine
the hypothesis of different vesicle populations, we performed
immunotitration experiments using varying amounts of 1F8
(bound to acrylamide) to adsorb GLUT4 vesicles in LDMs from
nonstimulated cells and determined the amount of recovered
GLUT4, GLUT1, and SCAMPs by Western blot analysis. We
found that about 10 times less 1F8 antibody (;0.7 mg) was
required to reach a saturating degree of GLUT4 adsorption
than was the case for either GLUT1 (7 mg of 1F8; Fig. 4) or
SCAMPs (Fig. 5). These observations thus confirm the exist-
ence of an intracellular vesicle pool that is enriched in GLUT4
but poor in GLUT1 and SCAMPs.
Finally, it was verified that the GLUT4-containing vesicles
immunoadsorbed with 1F8-acrylamide, as described above,
represents an insulin-sensitive pool. Therefore, the action of
insulin on the abundance of GLUT4, GLUT1, and SCAMP 39
was studied in GLUT4 vesicles immunoadsorbed with a satu-
rating amount of 1F8-acrylamide (to obtain GLUT4 vesicles
with a high content in GLUT1 and SCAMP 39; see above). In
this fraction, there was an insulin-dependent reduction in the
amount of GLUT4 (246%), GLUT1 (245%), and SCAMP 39
(259%) (Fig. 6A). Similarly, insulin reduced the GLUT4 con-
tent in GLUT4 vesicles obtained with 1F8-agarose (55% de-
crease; Fig. 6B).
DISCUSSION
Quantification of GLUT1 and GLUT4 and Insulin-dependent
Recruitment to the Plasma Membrane—A first issue addressed
in this study is the direct comparison of the contents of GLUT4
and GLUT1 in isolated rat cardiomyocytes and of the relative
contribution of these isoforms to the effect of insulin on glucose
uptake. As shown in Fig. 1, GLUT4 is recruited to the plasma
membrane to a larger extent than GLUT1 in response to insu-
lin, as quantified by ATB-BMPA labeling. This is confirmed by
experiments such as that illustrated in Fig. 2, in which the
relative effects of insulin on the level of GLUT4 and GLUT1
were evaluated in purified plasma membranes by Western blot
analysis. It is also worth mentioning that the absolute level of
ATB-BMPA labeling of GLUT4 at the surface of nonstimulated
cardiomyocytes already exceeded that of GLUT1 labeling by a
TABLE I
Recovery of GLUT4, GLUT1, and SCAMPs on immunoisolation of
intracellular membranes from unstimulated cardiac myocytes
LDM membranes obtained from nonstimulated cardiac myocytes
were immunoadsorbed with 1F8-agarose beads, 1F8-acrylic beads, 3F8-
agarose beads, or beads linked to nonspecific antibodies. After the
incubation, the adsorbed and nonadsorbed fractions were electrophore-
sed and immunoblotted to determine the abundance of GLUT4, GLUT1,
and SCAMPs. Autoradiograms were subjected to scanning densitome-
try. Data are means 6 S.E. of three to six experiments (with the
exception of data on GLUT1 after immunoadsorption with 3F8-agarose
beads, which are the mean of two observations) and expressed as
percentages of specific immunoadsorption.
Immunoadsorption agent GLUT4 SCAMP 39 GLUT1
% of specific immunoadsorption
1F8-agarose 60.1 6 2.2 24.2 6 7.1 15.2 6 2.7
1F8-acrylamide 79.2 6 0.9 55.4 6 7.1 63.7 6 6.6
3F8-agarose 36.6 6 5.7 63.0 6 15.6 24.7
FIG. 4. Immunotitration of GLUT4 and GLUT1 in intracellular
membranes from unstimulated cardiomyocytes. LDM mem-
branes obtained from nonstimulated cardiac myocytes were immuno-
adsorbed with increasing amounts of 1F8 acrylic beads (corresponding
to the 1F8 quantities indicated). GLUT4 and GLUT1 were detected in
the adsorbed fractions by Western blotting.Upper panel, representative
autoradiograms. Lower panel, quantitative analysis. The amounts of
immunoadsorbed GLUT4 and GLUT1 were determined by densitome-
try of autoradiograms such as those shown above and normalized to the
maximal amount precipitated with a saturating dose of 1F8 in the same
experiment. Data are means from two to five independent experiments.
(Note that the percentage values plotted here are not expressed in the
same way as those shown in Table I, which were normalized to the total
amount in LDM; e.g. 100% GLUT1 as plotted in this figure would be
equivalent to ;64% in Table I.)
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factor of ;2.5 (not shown), and the preferential recruitment of
GLUT4 by insulin will accentuate the importance of GLUT4 as
the predominant transporter in the plasma membrane. Thus,
these results clearly indicate that GLUT4 is responsible for a
large part of insulin-stimulated glucose uptake in these cells.
This is in line with prior observations in adipocytes and skel-
etal muscles (12–14, 16).
On the other hand, we found a high degree of GLUT1 ex-
pression in cardiomyocytes, as determined by quantitative
Western blot analysis, which confirms qualitative and semi-
quantitative data obtained by others in heart tissue (24, 25).
This high level of GLUT1 expression appears to be a unique
property of the heart among insulin-sensitive tissues. Thus,
GLUT1 accounts for only a very small percentage of total
glucose carriers (;5–10%) in adipocytes (19, 43) and skeletal
muscles (20, 25) (versus ;30% in cardiomyocytes). This large
amount of GLUT1 in cardiomyocytes, along with the observa-
tion that it is recruited by a variety of agents in these cells
(26–28), suggests that this transporter may play a specific role
in the regulation of cardiac glucose transport. Several patho-
physiological situations illustrate the possible importance of
GLUT1 for cardiac glucose uptake. For instance, it was re-
cently reported that the basal and insulin-dependent glucose
transport in isolated perfused rat hearts is decreased following
in vivo treatment with triiodothyronine (mimicking hyperthy-
roidism) (44), an intervention known to selectively reduce the
myocardial level of GLUT1 but not GLUT4 (45). Similarly,
fasting over 24–48 h was shown to dramatically diminish the
basal rate as well as the insulin sensitivity of myocardial glu-
cose uptake in vivo, with a concomitant reduction in the
amount of cardiac GLUT1 (25). It is also worth mentioning that
streptozotocin-induced diabetes also causes a decrease in
GLUT1 protein in the rat heart (46).
The fact that insulin induces a more modest translocation of
GLUT1 than GLUT4 suggests that the specific function of
GLUT1 in these cells lies in the mediation of other effects than
that of insulin. One possibility worth being explored is that the
intracellular GLUT1 pool of heart cells is more responsive to
stimuli such as contraction or anoxia than to insulin. In this
context, one may speculate that GLUT1 becomes redistributed
to this pool after cardiomyocyte isolation (e.g. as a consequence
of the arrest of contractile activity).
Characterization of Intracellular GLUT4-containing Mem-
branes—We have further explored the intracellular insulin-
sensitive GLUT4 pool by performing vesicle immunoisolation
analysis in LDMs from rat cardiomyocytes. Immunoadsorption
assays with 1F8-agarose resulted in a high recovery of GLUT4
but in a low recovery of GLUT1 and SCAMP 39; in contrast,
immunoadsorption with 1F8-acrylamide led to a large increase
in the amount of GLUT1 and SCAMP 39 recovered, with a
relatively modest increase in the degree of GLUT4 recovery
(Table I). In other words, immunoadsorption with 1F8-agarose
yields GLUT4 vesicles with a low GLUT1 and low SCAMP 39
content (GLUT4 pool 1), whereas immunoadsorption with 1F8-
acrylamide yields, in addition, GLUT4 vesicles with a high
GLUT1 and high SCAMP 39 content (GLUT4 pool 2). Further-
more, immunotitration experiments with LDM membranes
show that a much smaller amount of 1F8 is required to reach a
saturating degree of GLUT4 recovery than was the case for
GLUT1 (Fig. 4) or SCAMPs (Fig. 5). Thus, our data are com-
patible with the existence of at least two different intracellular
FIG. 5. Immunotitration of GLUT4 and SCAMPs in intracellu-
lar membranes from unstimulated cardiomyocytes. LDM mem-
branes were immunoadsorbed with increasing amounts of 1F8-acryl-
amide, and the content of GLUT4 and SCAMPs in the adsorbed
material was determined as described in the legend of Fig. 4. Upper
panel, representative autoradiograms. Lower panel, quantitative anal-
ysis. Data are means from four independent experiments and expressed
as in Fig. 4.
FIG. 6. Effect of insulin on the content of GLUT4, GLUT1, and
SCAMPs in immunoadsorbed intracellular GLUT4-containing
vesicles. LDM membranes obtained from basal (i.e. unstimulated) or
insulin-treated cardiac myocytes were immunoadsorbed with 1F8 (1) or
with antibodies from nonimmune serum (2) coupled to agarose beads
(upper panel) or to acrylamide beads (lower panel) as described under
“Materials and Methods.” The immunoadsorbed material was subse-
quently subjected to immunoblot. Representative autoradiograms of
three to eight separate experiments are shown.
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GLUT4 populations (see Fig. 7).
Immunocytochemical studies have localized GLUT4 in sev-
eral distinct intracellular sites in adipocytes (47) and cardiom-
yocytes (18). Furthermore, kinetic studies are indicative of the
existence of two intracellular GLUT4 pools in adipocytes. First,
mathematical analysis of kinetic data of GLUT4 endocytosis
and exocytosis obtained with the photoaffinity reagent ATB-
BMPA (6, 35) predicts that GLUT4 localizes to at least two
distinct intracellular compartments in fat cells (48). Second,
data of subcellular trafficking of both GLUT4 and GLUT1 and
chimeric transporters in adipocytes (49) are best explained by a
model postulating two intracellular pools (50). According to the
predictions of this model, GLUT4 is internalized into an endo-
somal compartment and then sorted into an insulin-recruitable
compartment; in contrast, GLUT1 is endocytosed into the en-
dosomal compartment and recycles from this compartment to
the cell surface (50). Further support to the idea that GLUT4 is
present in separate intracellular compartments comes from
very recent compartment ablation analysis; thus, ablation of
the endosomal compartment in 3T3-L1 adipocytes reduces by
40% the amount of cellular GLUT4 (51).
In view of all this and considering that SCAMPs are known
markers of the endosomal compartment (52), we propose that
GLUT4 pool 2 is of endosomal nature and might be similar to
the endosomal GLUT4 pool predicted in adipocytes (48, 50) (see
Fig. 7). Our finding that insulin depletes GLUT1 and SCAMP
39 from GLUT4 pool 2 is consistent with the model proposed by
Yeh et al. (50), according to which GLUT1 would recycle from
the endosomal compartment to the cell surface in adipocytes.
Furthermore, GLUT4 pool 1 might be analogous to the insulin-
recruitable compartment proposed by others on the basis of
kinetic (48, 50) and immunoadsorption (53) experiments. In
keeping with this, we found that GLUT4 was markedly de-
pleted from the 1F8-agarose immunoprecipitates after insulin
treatment (Fig. 6).
In this context, other experiments further support the notion
of a different intracellular location of GLUT4 and GLUT1.
Thus, quantitative Western blot analysis showed that the mo-
lar ratio of GLUT1:GLUT4 is much smaller in LDMs from
nonstimulated cardiomyocytes (0.1:1; not shown) than that
found in crude homogenates of these cells (0.4:1; see “Results”).
This suggests the existence of an additional GLUT1 pool that is
not part of LDMs (and is therefore distinct from pools 1 and 2).
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